Javascript er ikke aktivert i din nettleser. Dette er nødvendig for å bruke Oncolex. Kontakt din systemadministrator for å aktivere JavaScript.

Prognosis of acute leukemia

Acute Lymphoblastic Leukemia

The prognosis for survival of acute lymphoblastic leukemia of children in all stages is now > 80%.

Probability for 10 year survival in 289 Norwegian children with acute lymphoblastic leukemia diagnosed during 1992–2000.


Probability for survival without recurrence (p-EFS) in 289 children between 1–15 years with acute lymphoblastic leukemia in four risk groups treated according to the Nordic treatment protocol NOPHO-ALL 1992. Ten year recurrence-free survival for the entire group is 76%.

 Standard - intermediate - intensive -  highly intensive

Acute Myelogenous Leukemia

The prognosis for survival of acute myelogenous leukemia in children in Norway is 65%, which is unsurpassed internationally.

Oslo University Hospital shall not be liable for any loss whether direct, indirect, incidental or consequential, arising out of access to, use of, or reliance upon any of the content on this website. Oslo University Hospital© 2017